Received Jul 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z003309 | — |
No symptoms or side effects were reported by HCP. No other information reported by HCP. No additional AE/No PQC.; HCP reporting that a patient received a dose of improperly stored PROQUAD. HCP reported that she did not know the date the excursion occurred, but knows the PROQUAD was administered on 07/16/2025 following the excursion.; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 16-Jul-2025, the patient received a dose of improperly stored measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (PROQUAD) (lot #Z003309 has been verified to be a valid batch lot number, expiration date not reported, but upon internal validation established as 21-Jul-2026) 0.5 mL for prophylaxis by Health Professional, following a temperature excursion of 52.2 Fahrenheit (F), the reporter did not know the date the excursion occurred (Product storage error). No symptoms or side effects were reported (no adverse event) were reported.